User: Genecampaign Topic: IP
Category: patents :: everywhere
Last updated: Nov 21 2014 05:05 IST RSS 2.0
 
1 to 20 of 9,638    
Refrigerant gases, climate change and India 21.11.2014 Sify Finance
Despite India changing its stance and keeping quiet, select developing countries were able to delay the launch of formal talks on the phasing out of climate change-causing refrigerant gases under the
Also found in: [+]
Drug spending tops $1 trillion on hepatitis C, cancer therapies: Study 20.11.2014 ET: Healthcare
Hepatitis C drugs will add about $100 billion in total spending in the next few years, while cancer spending will rise to $100 billion.
Also found in: [+]
Seven of the 30 largest corporations in US paid more to their CEOs than they did in taxes, study finds 19.11.2014 The Guardian -- Front Page

This most recent gap between executive pay and taxes is part of an alarming trend reflecting a generous corporate tax code

Which would you think would be larger for Ford Motor, a company that last year reported revenues of $139.4b: the taxes it pays the US federal government or the compensation it pays its CEO?

If you picked option B, congratulations – you may be cynical, but you’re right. Alan Mulally, Ford’s CEO, pocketed a compensation package that totaled $23.2m while Ford itself got a US federal tax refund of $19m.

You may sell your wedding ring to buy food. But you don't get a tax holiday. Life is easier for a corporation.

Continue reading...
Also found in: [+]
Ranbaxy drags US drug regulator to court 19.11.2014 Rediff: Business
Ranbaxy files case over revoking approvals; US health secretary named in lawsuit.
Also found in: [+]
Govt’s engagement with MNCs on patent protection keeps domestic industry on edge 19.11.2014 TOI: India Business
The government's intention to engage with multinational companies and patent lawyers to discuss protection and enforcement of intellectual property rights in India has triggered concerns from the civil society, local firms and those advocating affordable medicines.
Also found in: [+]
Ranbaxy sues FDA for revoking approvals 19.11.2014 Telegraph: Business
Ranbaxy Laboratories has sued the US Food and Drug Administration (FDA) for revoking approvals to launch the generic versions of AstraZeneca's heartburn pill Nexium and Roche AG's anti-viral drug Valcyte.
Also found in: [+]
Ranbaxy drags US FDA to court 19.11.2014 Sify Finance
In an unprecedented move, generic drug maker Ranbaxy has sued the US Food & Drug Administration (US FDA) for revoking the approvals to two of its key drugs
Also found in: [+]
Nokia returns to gadgets business; launches Android tablet 18.11.2014 Rediff: Top Stories (India)
Within a year of selling its handset and services business to Microsoft, Nokia has again entered the mobile devices segment by unveiling a new tablet N1 in partnership with Taiwanese company Foxconn.
Also found in: [+]
IPR policy and India's competitiveness (Column: Active Voice) 18.11.2014 Sify Finance
's current Intellectual Property Rights (IPR) regime is at the cusp of a major
Also found in: [+]
Nokia makes a comeback: Launches Android tablet N1 18.11.2014 Sify Finance
Also found in: [+]
Foreign drug makers urge government to review IPR think tank 18.11.2014 ET: Pharma
A similar point has also been raised by the US biotech groupings PhRMA and BIO in their submissions to the US Trade Representative's office.
Also found in: [+]
Government holding IP conference with MNCs, their lawyers, excluding civil society, academics 17.11.2014 India News, Latest News in India, Live News India, India Breaking News - Times of India
The government of India claims to seek balance of public and private interests in intellectual property ...
Also found in: [+]
Drug makers alter US strategy 17.11.2014 Telegraph: Business
Mumbai, Nov. 16: Domestic pharmaceutical companies are focusing on strong products from their existing portfolio to drive growth in the face of delay in approvals for new generic drug applications by the US Food and Drug Administration (FDA).
Also found in: [+]
Sualkuchi silk sees ray of hope in new innovations 16.11.2014 The Assam Tribune
Sualkuchi silk sees ray of hope in new innovations
Also found in: [+]
Alarm rings on drug patent meetings 16.11.2014 Telegraph: Nation
New Delhi, Nov. 15: An Indian consortium of health activists has expressed concern that an American organisation representing large pharmaceutical corporations plans to meet Indian patent controllers and visit the Supreme Court and Delhi High Court next week.
Also found in: [+]
Group writes to SC, HC CJs against US patent body 16.11.2014 India News, Latest News in India, Live News India, India Breaking News - Times of India
The IPOA delegation comprises representatives of pharma MNCs with interests in India and the law firms that represent them in patent disputes before the IPAB and Indian ...
Also found in: [+]
Appeal to chief justices to cancel meetings with US patent lobby 15.11.2014 TOI: India
The Campaign for Affordable Transtuzumab, a group of individuals and organisations fighting to increase access to medicines, has written to the chief justices of the Supreme Court and the Delhi Court and to the chairperson of the Intellectual Property Appellate Board (IPAB) expressing grave concern over the meetings scheduled by the US lobby group, Intellectual Property Owners Association (IPOA) with IPAB, a quasi-judicial body, the Delhi High Court and the offices of the Controller of ...
Also found in: [+]
US patent lobby to meet Indian judiciary, patent officials: Conflict of interest? 13.11.2014 TOI: India
In a glaring instance of conflict of interest many pharmaceutical MNC representatives from the US will be meeting members of judicial tribunals and higher judiciary and officers who are dealing with intellectual property (IP) cases of these companies on a visit to India next ...
Also found in: [+]
India, US IPR dialogue to begin this month 12.11.2014 Sify Finance
The US seems to be subtly upping the ante against India on intellectual property rights (IPR). While the US has launched the out-of-cycle-reviews, or OCR, under Special 301 Report, it will also pursue
Also found in: [+]
George Osborne waters down flagship controversial tax break 11.11.2014 The Guardian -- Front Page
Patent boxes allow firms to pay much lower taxes on profits from patented inventions, but critics say it gives UK too much of a fiscal advantage

George Osborne has watered down one of his flagship policies following a long-running dispute with Germany over a controversial UK tax break.

The chancellors move on so-called patent boxes which allowed companies to pay much lower taxes on profits from patented inventions removes one of the potential flash points between the UK and Germany before this weeks G20 summit in Brisbane.

Continue reading...
Also found in: [+]
1 to 20 of 9,638